A Great Tool For Biotech Traders – BioPharmCatalyst.com:
BioPharmCatalyst.com is a phenomenal resource for uncovering catalyst events within the biotechnology sector. Such catalysts include Phase 1/2/3 trial data releases, FDA Approval/PDUFA, Advisory Committee (AdCom) Meetings, etc. With an understanding of such events, biotech traders and investors are able to perform their due diligence on pipeline drugs and have a timeline of expected developments. Best of all, the platform is completely free to use and provides supplemental newsletters for interested users: Biopharm Catalyst Biotech Stock Watch List (weekly), Biotech Stock Price Movers (daily), and Pipeline Database Updates (daily).
It’s an undeniable fact that catalysts can be a major reason for why stocks move. Inherently, that’s what catalysts are – reasons for a stock to move in one direction or another. If traders and investors can position themselves correctly before a particular catalyst (or set of catalysts) is priced in, then there’s a lot of room for profit along the way. One of the best small and mid-cap biotech traders on Wall Street, Kyle Dennis, pairs simple technical analysis concepts with high-quality catalysts to capture consistent profits within the sector. At this point in time, he’s made over $2,000,000 in about three years. The BioPharmCatalyst platform is one of Kyle’s “secret weapons” for researching and planning biotech trades.